Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now

Becton, Dickinson and Company (BDX) , popularly known as BD, is well-poised for growth in the coming quarters, courtesy of its solid product portfolio. The optimism led by a solid second-quarter fiscal 2024 performance and a few strategic deals are expected to contribute further. However, macroeconomic concerns and stiff competition persist. Over the past year, this Zacks Rank #3 (Hold) stock has lost 5.2% against the 4% rise of the industry and 23.3% growth of the S&P 500. The renowned medical technology c ...